Brain
Posted on: Aug 16 Hosted By: Dr. Kathy Miller
Brain
Posted on: Aug 16 Hosted By: Dr. Kathy Miller
Views12901 Shares0
Tags: neurology, neurosurgery, brain, tumors, podcast

New Outlook on Primary Brain Tumors

Guest: Dr. Stephanie Wagner

Brain cancer has a unique set of challenges, most importantly cognitive and medically based ones. In this podcast, Dr. Stephanie Wagner, neuro-oncologist at Indiana University Health, discusses the differences between primary tumors and metastatic brain cancers and articulates the cognitive (i.e., fatigue, short-term memory loss, mood changes, personality disorders) and medically based challenges that patients and caregivers face. She talks about the difficulties of surgical intervention and radiotherapy and the lack of treatment choices compared with other solid tumors.

She articulates how the blood brain barrier prevents drug intervention and discusses how drugs like Avastin, which cross the barrier and provide angiogenic activity to tumor vascularity, may help. Drs. Wagner and Miller discuss how Avastin works in the adjuvant setting compared with radiation and chemotherapy, and in which patients it is best used. Phase II research on vaccines and combination therapy are also reviewed.
 

Tags: neurology, neurosurgery, brain, tumors, podcast
What do you think of this podcast?

New Outlook on Primary Brain Tumors

Guest: Dr. Stephanie Wagner

Brain cancer has a unique set of challenges, most importantly cognitive and medically based ones. In this podcast, Dr. Stephanie Wagner, neuro-oncologist at Indiana University Health, discusses the differences between primary tumors and metastatic brain cancers and articulates the cognitive (i.e., fatigue, short-term memory loss, mood changes, personality disorders) and medically based challenges that patients and caregivers face. She talks about the difficulties of surgical intervention and radiotherapy and the lack of treatment choices compared with other solid tumors.

She articulates how the blood brain barrier prevents drug intervention and discusses how drugs like Avastin, which cross the barrier and provide angiogenic activity to tumor vascularity, may help. Drs. Wagner and Miller discuss how Avastin works in the adjuvant setting compared with radiation and chemotherapy, and in which patients it is best used. Phase II research on vaccines and combination therapy are also reviewed.
 

What do you think of this podcast? print